These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22761762)

  • 1. 92-Gene molecular profiling in identification of cancer origin: a retrospective study in Chinese population and performance within different subgroups.
    Wu F; Huang D; Wang L; Xu Q; Liu F; Ye X; Meng X; Du X
    PLoS One; 2012; 7(6):e39320. PubMed ID: 22761762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling from formalin-fixed, paraffin-embedded tissue for tumor diagnosis.
    Grenert JP; Smith A; Ruan W; Pillai R; Wu AH
    Clin Chim Acta; 2011 Jul; 412(15-16):1462-4. PubMed ID: 21497155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimens.
    Pillai R; Deeter R; Rigl CT; Nystrom JS; Miller MH; Buturovic L; Henner WD
    J Mol Diagn; 2011 Jan; 13(1):48-56. PubMed ID: 21227394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling in unknown primary cancer: accuracy of tissue of origin prediction.
    Greco FA; Spigel DR; Yardley DA; Erlander MG; Ma XJ; Hainsworth JD
    Oncologist; 2010; 15(5):500-6. PubMed ID: 20427384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
    Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
    Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients.
    Sun W; Wu W; Wang Q; Yao Q; Feng Q; Wang Y; Sun Y; Liu Y; Lai Q; Zhang G; Qi P; Sun Y; Qian C; Ren W; Luo Z; Chen J; Wang H; Xu Q; Zhou X; Sun W; Lin D
    J Transl Med; 2022 Mar; 20(1):114. PubMed ID: 35255924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter validation of a 1,550-gene expression profile for identification of tumor tissue of origin.
    Monzon FA; Lyons-Weiler M; Buturovic LJ; Rigl CT; Henner WD; Sciulli C; Dumur CI; Medeiros F; Anderson GG
    J Clin Oncol; 2009 May; 27(15):2503-8. PubMed ID: 19332734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
    Hainsworth JD; Schnabel CA; Erlander MG; Haines DW; Greco FA
    Clin Colorectal Cancer; 2012 Jun; 11(2):112-8. PubMed ID: 22000811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of tissue of origin in body fluid specimens using a gene expression microarray assay.
    Stancel GA; Coffey D; Alvarez K; Halks-Miller M; Lal A; Mody D; Koen T; Fairley T; Monzon FA
    Cancer Cytopathol; 2012 Feb; 120(1):62-70. PubMed ID: 21717591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Method to Correlate mRNA Expression Datasets Obtained from Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Tissue Samples: A Matter of Thresholds.
    Mustafa DA; Sieuwerts AM; Smid M; de Weerd V; van der Weiden M; Meijer-van Gelder ME; Martens JW; Foekens JA; Kros JM
    PLoS One; 2015; 10(12):e0144097. PubMed ID: 26716838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit of Gene Expression Profiling in Gastrointestinal Neuroendocrine Tumors of Unknown Primary Origin.
    Saller JJ; Haider M; Al-Diffalha S; Coppola D
    Anticancer Res; 2022 Mar; 42(3):1381-1396. PubMed ID: 35220231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FFPE tissue as a feasible source for gene expression analysis--a comparison of three reference genes and one tumor marker.
    Walter RF; Mairinger FD; Wohlschlaeger J; Worm K; Ting S; Vollbrecht C; Schmid KW; Hager T
    Pathol Res Pract; 2013 Dec; 209(12):784-9. PubMed ID: 24156825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primary.
    Laprovitera N; Riefolo M; Porcellini E; Durante G; Garajova I; Vasuri F; Aigelsreiter A; Dandachi N; Benvenuto G; Agostinis F; Sabbioni S; Berindan Neagoe I; Romualdi C; Ardizzoni A; Trerè D; Pichler M; D'Errico A; Ferracin M
    Mol Oncol; 2021 Oct; 15(10):2732-2751. PubMed ID: 34075699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated tool for determining the primary origin site of metastatic tumours.
    Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL
    J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MammaPrint molecular diagnostics on formalin-fixed, paraffin-embedded tissue.
    Sapino A; Roepman P; Linn SC; Snel MH; Delahaye LJ; van den Akker J; Glas AM; Simon IM; Barth N; de Snoo FA; van 't Veer LJ; Molinaro L; Berns EM; Wesseling J; Riley LB; Anderson D; Nguyen B; Cox CE
    J Mol Diagn; 2014 Mar; 16(2):190-7. PubMed ID: 24378251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.
    April C; Klotzle B; Royce T; Wickham-Garcia E; Boyaniwsky T; Izzo J; Cox D; Jones W; Rubio R; Holton K; Matulonis U; Quackenbush J; Fan JB
    PLoS One; 2009 Dec; 4(12):e8162. PubMed ID: 19997620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
    Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
    Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles help identify the tissue of origin for metastatic brain cancers.
    Wu AH; Drees JC; Wang H; VandenBerg SR; Lal A; Henner WD; Pillai R
    Diagn Pathol; 2010 Apr; 5():26. PubMed ID: 20420692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples.
    Brachtel EF; Operaña TN; Sullivan PS; Kerr SE; Cherkis KA; Schroeder BE; Dry SM; Schnabel CA
    Oncotarget; 2016 May; 7(19):27220-31. PubMed ID: 27034010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.